We defined groups of genes as ARNT-specific or BMAL1-specific by RNA sequencing of ccRCC patient-derived cell lines in which ARNT or BMAL1 is depleted by shRNA. This evidence concerns the gene BMAL1 and nonpapillary renal cell carcinoma.